Capricorn Scientific Expands European Infrastructure to Drive Scalable Biotech & Pharma Growth
Capricorn Scientific is expanding its European footprint with a new 4,000 m² logistics and infrastructure hub in Ebsdorfergrund, Germany – designed to strengthen supply security, scalability, and long-term partnerships in regulated life science markets. Strategically located near Marburg and Frankfurt am Main, with fast access to Frankfurt International Airport, the site enables efficient national and global distribution of cell culture products. The expansion is designed to reduce supply-chain risk while enabling predictable, long-term growth across biotech, pharma, diagnostics, and cell therapy markets.
Built for performance and growth, the facility features a modern, modular layout with optimized truck access, multiple loading docks, and clearly separated logistics zones for smooth, high-throughput operations. Expanded temperature-controlled storage (+2 to +8 °C, −20 °C, and humidity-controlled room temperature) ensures reliable handling of sensitive products—even during demand peaks.
Security and quality are embedded by design: access-controlled areas and cGMP-aligned processes support customers operating in highly regulated upstream and downstream environments. Further expansion is already underway, with planned additions for liquid bag filling, scaled powder production, and dedicated R&D space, creating a future-ready platform from logistics to production and innovation—all supported by integrated, modern office spaces for fast and efficient collaboration.
With this expansion, Capricorn Scientific plans to create up to 40 new jobs over the next two years, reinforcing its long-term commitment to Germany as a key location for innovation, quality, and sustainable growth.
For customers, the new infrastructure translates into tangible advantages: greater supply security, shorter lead times from order to delivery, stable and standardized processes, and flexible call-off models for framework agreements and long-term partnerships. The site is designed to support both project-based and serial production while ensuring transparent logistics processes for key accounts and partners.
By investing in its own European infrastructure, Capricorn Scientific maintains direct control over logistics, storage, and future production. Customers benefit from high delivery reliability, scalable solutions without technology breaks – from small development quantities to industrial batch sizes – and a strong focus on quality, compliance, and customer-centric solutions. With deep experience in biotech, pharma, diagnostics, and cell therapy, Capricorn Scientific continues to pursue a future-oriented strategy focused on serum-free, defined, and sustainable solutions. For more details, visit www.capricorn-scientific.com or contact info@capricorn-scientific.com.
Total Page Views: 147












